421 related articles for article (PubMed ID: 34445199)
1. What Genetics Has Told Us and How It Can Inform Future Experiments for Spinal Muscular Atrophy, a Perspective.
Blatnik AJ; McGovern VL; Burghes AHM
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445199
[TBL] [Abstract][Full Text] [Related]
2. The Biochemistry of Survival Motor Neuron Protein Is Paving the Way to Novel Therapies for Spinal Muscle Atrophy.
Lomonte P; Baklouti F; Binda O
Biochemistry; 2020 Apr; 59(14):1391-1397. PubMed ID: 32227847
[TBL] [Abstract][Full Text] [Related]
3. A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice.
Workman E; Saieva L; Carrel TL; Crawford TO; Liu D; Lutz C; Beattie CE; Pellizzoni L; Burghes AH
Hum Mol Genet; 2009 Jun; 18(12):2215-29. PubMed ID: 19329542
[TBL] [Abstract][Full Text] [Related]
4. RNA-sequencing of a mouse-model of spinal muscular atrophy reveals tissue-wide changes in splicing of U12-dependent introns.
Doktor TK; Hua Y; Andersen HS; Brøner S; Liu YH; Wieckowska A; Dembic M; Bruun GH; Krainer AR; Andresen BS
Nucleic Acids Res; 2017 Jan; 45(1):395-416. PubMed ID: 27557711
[TBL] [Abstract][Full Text] [Related]
5. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration.
Arnold WD; Duque S; Iyer CC; Zaworski P; McGovern VL; Taylor SJ; von Herrmann KM; Kobayashi DT; Chen KS; Kolb SJ; Paushkin SV; Burghes AH
PLoS One; 2016; 11(12):e0167077. PubMed ID: 27907033
[TBL] [Abstract][Full Text] [Related]
6. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
[TBL] [Abstract][Full Text] [Related]
7. Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn
Reedich EJ; Kalski M; Armijo N; Cox GA; DiDonato CJ
Exp Neurol; 2021 Mar; 337():113587. PubMed ID: 33382987
[TBL] [Abstract][Full Text] [Related]
8. Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein.
Anderton RS; Meloni BP; Mastaglia FL; Boulos S
Mol Neurobiol; 2013 Apr; 47(2):821-32. PubMed ID: 23315303
[TBL] [Abstract][Full Text] [Related]
9. Recapitulation of spinal motor neuron-specific disease phenotypes in a human cell model of spinal muscular atrophy.
Wang ZB; Zhang X; Li XJ
Cell Res; 2013 Mar; 23(3):378-93. PubMed ID: 23208423
[TBL] [Abstract][Full Text] [Related]
10. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.
Park GH; Maeno-Hikichi Y; Awano T; Landmesser LT; Monani UR
J Neurosci; 2010 Sep; 30(36):12005-19. PubMed ID: 20826664
[TBL] [Abstract][Full Text] [Related]
11. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.
Hua Y; Sahashi K; Rigo F; Hung G; Horev G; Bennett CF; Krainer AR
Nature; 2011 Oct; 478(7367):123-6. PubMed ID: 21979052
[TBL] [Abstract][Full Text] [Related]
12. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.
Ahmad S; Wang Y; Shaik GM; Burghes AH; Gangwani L
Hum Mol Genet; 2012 Jun; 21(12):2745-58. PubMed ID: 22422766
[TBL] [Abstract][Full Text] [Related]
13. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Burghes AH; Beattie CE
Nat Rev Neurosci; 2009 Aug; 10(8):597-609. PubMed ID: 19584893
[TBL] [Abstract][Full Text] [Related]
14. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ
Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset.
Feng Z; Ling KK; Zhao X; Zhou C; Karp G; Welch EM; Naryshkin N; Ratni H; Chen KS; Metzger F; Paushkin S; Weetall M; Ko CP
Hum Mol Genet; 2016 Mar; 25(5):964-75. PubMed ID: 26758873
[TBL] [Abstract][Full Text] [Related]
16. Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion.
Martin JE; Nguyen TT; Grunseich C; Nofziger JH; Lee PR; Fields D; Fischbeck KH; Foran E
J Neurosci; 2017 May; 37(21):5309-5318. PubMed ID: 28450545
[TBL] [Abstract][Full Text] [Related]
17. SMN in spinal muscular atrophy and snRNP biogenesis.
Coady TH; Lorson CL
Wiley Interdiscip Rev RNA; 2011; 2(4):546-64. PubMed ID: 21957043
[TBL] [Abstract][Full Text] [Related]
18. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.
Martinez TL; Kong L; Wang X; Osborne MA; Crowder ME; Van Meerbeke JP; Xu X; Davis C; Wooley J; Goldhamer DJ; Lutz CM; Rich MM; Sumner CJ
J Neurosci; 2012 Jun; 32(25):8703-15. PubMed ID: 22723710
[TBL] [Abstract][Full Text] [Related]
19. Restoration of SMN to Emx-1 expressing cortical neurons is not sufficient to provide benefit to a severe mouse model of Spinal Muscular Atrophy.
Taylor AS; Glascock JJ; Rose FF; Lutz C; Lorson CL
Transgenic Res; 2013 Oct; 22(5):1029-36. PubMed ID: 23512182
[TBL] [Abstract][Full Text] [Related]
20. Notch Signaling Mediates Astrocyte Abnormality in Spinal Muscular Atrophy Model Systems.
Ohuchi K; Funato M; Yoshino Y; Ando S; Inagaki S; Sato A; Kawase C; Seki J; Saito T; Nishio H; Nakamura S; Shimazawa M; Kaneko H; Hara H
Sci Rep; 2019 Mar; 9(1):3701. PubMed ID: 30842449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
